Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ACTELION PHARMACEUTICALS LTD. et al v. APOTEX INC. et al
Case Number:
1:12-cv-05743
Court:
Nature of Suit:
Judge:
Firms
Companies
- Actelion Ltd.
- Allergan PLC
- Apotex Inc.
- Association for Accessible Medicines
- Johnson Matthey PLC
- Teva Pharmaceutical Industries Ltd.
- Zydus Pharmaceuticals Inc.
Government Agencies
Sectors & Industries:
-
February 28, 2014
Actelion Settles Row Over Giving Drugs To Generics Makers
Actelion Pharmaceuticals Ltd. reached a settlement with generic-drug makers in its quest for a New Jersey federal court to confirm antitrust laws don't require the company to supply its patented blood pressure drug Tracleer for generics development, according to an order dismissing the case Friday.
-
October 21, 2013
Actelion Denied Judgment In Tracleer Antitrust Suit
A New Jersey federal judge on Monday rejected Actelion Pharmaceuticals Ltd.'s bid for a quick end to its lawsuit claiming antitrust laws don't require it to supply its Tracleer blood pressure medicine to aid in developing generics, ruling in favor of several generic-drug makers and ordering the case to proceed to discovery.
-
March 12, 2013
FTC's Take On Drug Sales To Rivals May Cost Pharma
The Federal Trade Commission on Monday urged a New Jersey court to keep alive a case accusing Actelion Pharmaceutical Ltd. of breaching antitrust laws by refusing to supply generic rivals with samples of drugs covered by rules restricting distribution, a move that could force pharmaceutical companies to fight out expensive litigation and extend to other industries like the high-tech sector.
-
January 17, 2013
Actelion Says Antitrust Law Can't Make It Sell To Rivals
Actelion Pharmaceuticals Ltd. on Wednesday pressed a New Jersey federal court for a judgment in its case against Apotex Inc. and other drugmakers that are seeking to buy samples of its patented blood pressure medication, saying no antitrust law compels it to do business with its rivals.
-
September 14, 2012
Actelion Sues To Keep Tracleer Away From Apotex, Roxane
Actelion Pharmaceuticals Ltd. sued Apotex Inc. and Roxane Laboratories Inc. in New Jersey federal court Friday to confirm antitrust laws don't require it to supply its Tracleer blood pressure medicine to aid development of generics, potentially heralding a momentous decision for drugmakers.